The COVID-19 pandemic helped to showcase RNA molecules and their therapeutic potential. There were also lessons learned in terms of drug delivery, manufacturing, logistics, and storage.
Marina Necdina
Advertisement
Marina Necdina is a business development manager, former pharma analyst, and research scientist.
Articles by Marina Necdina
New medications show exciting outcomes for weight loss.
Advertisement
Latest Updated Articles
- The COVID-19 Pandemic and Its Positive Impact on RNA Drug Development
Published: January 31st 2023 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
2
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
3
BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints
4
Q&A: Strategies for Supply Chain Resilience and Next-Generation Process Optimization
5
